Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=xomaLatest Financial News for XOMA Ltd.en-usTue, 22 Dec 2009 15:09:46 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh68838_2009-12-22_15-09-46_sge5bl0fh_newsml&rpc=44&type=marketsNewsyahoo_finance/396204394Tue, 22 Dec 2009 15:09:46 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091222/180747.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, today announced that, as a result of an improvement in the Company's financial status and in particular its full repayment of an outstanding loan, at the Company's request, its independent registered public accounting firm, Ernst & Young LLP, has agreed to remove a qualification regarding the Company's ability to continue as a going concern in an updated report on the Company's financial statements for the fiscal year ended December 31, 2008.yahoo_finance/474364907Tue, 22 Dec 2009 14:10:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091222/xoma8-k.htmlyahoo_finance/4027930829Tue, 22 Dec 2009 13:15:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091210/180036.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, reported results demonstrating the advantages of its monoclonal antibody technologies in the rapid development of a first-in-class multiple antibody product candidate, XOMA 3AB.yahoo_finance/2541717073Thu, 10 Dec 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1366sud2h/*http%3A//seekingalpha.com/article/177492-graft-versus-host-disease-failures-and-future-opportunities?source=yahooyahoo_finance/2921595758Thu, 10 Dec 2009 09:55:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091209/xoma8-k_a.htmlyahoo_finance/3229980974Wed, 9 Dec 2009 21:18:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091209/179949.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that it received a Letter of Reprimand from the staff of The NASDAQ Stock Market LLC on December 8, 2009 for non-compliance with NASDAQ's Listing Rule 5635 in connection with XOMA's previously-announced common share financing completed on September 30, 2009.yahoo_finance/441092796Wed, 9 Dec 2009 15:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=133uc78oi/*http%3A//www.fool.com/investing/general/2009/12/07/4-more-stocks-on-wall-streets-dollar-menu.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/4169809609Mon, 7 Dec 2009 21:17:49 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091119/xoma8-k.htmlyahoo_finance/2337127334Thu, 19 Nov 2009 21:31:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091119/178831.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that it received a letter from the staff of The NASDAQ Stock Market LLC on November 13, 2009 indicating that the NASDAQ staff has concluded that XOMA's previously-announced common share financing completed on September 30, 2009 did not comply with NASDAQ's Listing Rule 5635.yahoo_finance/1076670951Thu, 19 Nov 2009 21:09:10 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=XOMAyahoo_finance/2648745476Wed, 18 Nov 2009 12:22:35 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178559.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, today announced that James R. Neal has joined the company as Vice President, Business Development.yahoo_finance/344199170Tue, 17 Nov 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1343sgev3/*http%3A//www.thestreet.com/_yahoo/story/10626568/1/biotech-stock-mailbag-cardium-therapeutics.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3681583650Fri, 13 Nov 2009 18:01:13 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=xomayahoo_finance/4051815653Fri, 13 Nov 2009 14:05:50 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178307.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced its anti-inflammatory antibody to interleukin-1 beta , XOMA 052, has been selected as a Top Ten Cardiovascular/metabolic Project to Watch for partnering opportunities.yahoo_finance/305862102Thu, 12 Nov 2009 20:17:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091111/178192.html?.v=1BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that Fred Kurland, Vice President and Chief Financial Officer of XOMA, is scheduled to present at the 6th annual Lazard Healthcare Conference on Wednesday, November 18, at 1:45 pm.yahoo_finance/4139883375Wed, 11 Nov 2009 19:30:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/xoma10-q.htmlyahoo_finance/3193967444Mon, 9 Nov 2009 20:44:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=131jv0vuu/*http%3A//www.thestreet.com/_yahoo/story/10624093/1/doc-offers-top-hep-c-drug-picks-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1913369492Mon, 9 Nov 2009 18:54:15 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=12kcjrum9/*http%3A//seekingalpha.com/article/172261-xoma-ltd-q3-2009-earnings-call-transcript?source=yahooyahoo_finance/546223016Mon, 9 Nov 2009 18:19:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13cgrg7n6/*http%3A//www.thestreet.com/_yahoo/story/10623920/1/xoma-waffles-on-timing-of-drug-partnership-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2912631424Mon, 9 Nov 2009 15:23:17 Etc/GMT